Companies · Other

Generic Medical Devices Inc

GIG HARBOR · Other

Diligence memoA one-page analyst read on Generic Medical Devices Inc — recommendation, valuation, rhythm, risks.
$16.9M
Total raised · real
5
Rounds
0.2×
Latest step-up
Top 17%
Sector rank · raised
Series A
Latest stage · inferred · Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time)

Generic Medical Devices Inc looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.15× the median modeled value of Series A Other companies in 2010–2012 (632 peers) — value vs value, same stage and era.
Dormant
  • Last raise 14.8 yr ago; this sector typically re-raises about every 11 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other

Generic Medical Devices Inc is one of 25008 Other companies tracked from GIG HARBOR. By capital raised it ranks in the upper tier (ahead of 84% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$25M$50M$75M$100MSeries A · 2009-04-17 Raised $5.0M (real) Modeled valuation $75M (est)$5.0M$75MSeries A2009Series A · 2010-04-16 Raised $950K (real) Modeled valuation $14M (est)$950K$14MSeries A2010Series A · 2010-11-05 Raised $5.7M (real) Modeled valuation $86M (est)$5.7M$86MSeries A2010Series A · 2010-11-05 Raised $4.3M (real) Modeled valuation $66M (est)$4.3M$66MSeries A2010Series A · 2011-09-13 Raised $906K (real) Modeled valuation $14M (est)$906K$14MSeries A2011+$950K+$5.7M+$4.3M+$906KCumulative $17M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$5.0M · 2009
Series A extension$950K · 2010
Series A extension$5.7M · 2010
Series A extension$4.3M · 2010
Series A extension$906K · 2011

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 33%.

Modeled valuation trajectory
$13.7M
Base estimate est.
$1.2M
Conservative case
$74.6M
Upside case
$4.1M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks. Directional, not a quoted figure.

Series A · modeled $75.4M · 2009-04-172009Series A · modeled $14.4M · 2010-04-16Series A · modeled $86.2M · 2010-11-05Series A · modeled $65.8M · 2010-11-05Series A · modeled $13.7M · 2011-09-132011
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
55%
Survival probability
30% low · 75% high
1.35×/yr
Annual markup
1.70×/yr upside case
6.0 yr
Elapsed time used
14.8 yr actual, capped for stale marks
general
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
7 mo
Avg between rounds
$7.0M/yr
Capital velocity
17.2 yr
On record since
2009
First round
5
Rounds on file
How it compares to the market

Benchmarked against 25008 companies in Other. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 8.3× above median
This company$16.9M
Sector median$2.0M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.2× of median
This company$906K
Sector median$5.7M
Modeled value — vs sector median (estimate, all stages) 0.8× of median
This company$13.7M
Sector median$17.7M

Raised more than 84% of sector peers (real $). Modeled value above 45% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #604 of 632.

This companyCohort peer
$10.0M$100.0M$1.0B$10.0M$100.0MCapital raised (log)SWMF Life Science Venture Fund, Limited Partnership · Series A Raised $15.0M · modeled $227.0M (est)PrimaLoft Holding Company, LLC · Series A Raised $15.0M · modeled $227.0M (est)Applied Merchant Systems West Coast, Inc. · Series A Raised $15.0M · modeled $227.0M (est)Graphics Properties Holdings, Inc. · Series A Raised $15.0M · modeled $227.0M (est)Avi-Spl Holdings, Inc. · Series A Raised $28.0M · modeled $227.0M (est)Worldview Entertainment Capital Llc · Series A Raised $15.0M · modeled $227.0M (est)TRA Global Inc · Series A Raised $29.3M · modeled $227.0M (est)Anytime Worldwide Llc · Series A Raised $15.0M · modeled $227.0M (est)Animoto, Inc. · Series A Raised $19.4M · modeled $227.0M (est)Strategic Marketing Holdings, LLC · Series A Raised $14.8M · modeled $223.2M (est)International Rail Partners LLC · Series A Raised $14.6M · modeled $220.2M (est)Lifeline Capital Management, LLC · Series A Raised $16.0M · modeled $219.4M (est)Generic Medical Devices Inc (this company) Raised $16.9M · modeled $13.7M (est)Generic Medical Devices Inc
CompanyStageRaised · realValue · estvs peer med.
SWMF Life Science Venture Fund, Limited PartnershipSeries A$15.0M$227.0M2.50×
PrimaLoft Holding Company, LLCSeries A$15.0M$227.0M2.50×
Applied Merchant Systems West Coast, Inc.Series A$15.0M$227.0M2.50×
Graphics Properties Holdings, Inc.Series A$15.0M$227.0M2.50×
Avi-Spl Holdings, Inc.Series A$28.0M$227.0M2.50×
Worldview Entertainment Capital LlcSeries A$15.0M$227.0M2.50×
TRA Global IncSeries A$29.3M$227.0M2.50×
Anytime Worldwide LlcSeries A$15.0M$227.0M2.50×
Animoto, Inc.Series A$19.4M$227.0M2.50×
Strategic Marketing Holdings, LLCSeries A$14.8M$223.2M2.46×
International Rail Partners LLCSeries A$14.6M$220.2M2.43×
Lifeline Capital Management, LLCSeries A$16.0M$219.4M2.42×
Generic Medical Devices Inc this companySeries A$16.9M$13.7M0.15×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$5.0M2009-04-17$22.6M$75.4M90%
Series A$950K2010-04-16$4.3M$14.4M90%
Series A$5.7M2010-11-05$25.9M$86.2M90%
Series A$4.3M2010-11-05$19.8M$65.8M90%
Series A$906K2011-09-13$4.1M$13.7M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$5.0M2009-04-17
    • First recorded raise — entered as Series A.
  2. Series A$950K2010-04-16
    • Raised 12 mo later, in step with the ~11 mo sector norm.
    • Round 5.2× smaller than the prior — bridge or down round.
  3. Series A$5.7M2010-11-05
    • Came back fast: 7 mo vs the ~11 mo sector norm.
    • Round 6.0× larger than the prior — scaling up.
  4. Series A$4.3M2010-11-05
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.3× smaller than the prior — bridge or down round.
  5. Series A$906K2011-09-13
    • Raised 10 mo later, in step with the ~11 mo sector norm.
    • Round 4.8× smaller than the prior — bridge or down round.
Intelligence
2012 ~Q2
Modeled next raise · ~7mo cadence
$906K
Modeled next size est.range $906K$1.4M
0.2×
Last step-up
$7.0M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Peter Fitzgerald5 other2010-04
David Schulte3 other2009-04
Bruce J Brumfield2 other2009-04
Pamela B. Westbrook1 other2009-04
Richard P. Kuntz1 other2009-04
Robert Cummins1 other2010-04
Stephen M. Salmon1 other2009-04
Bruce Brumfield2010-04
David R. Schulte2010-04
Jay P. Brumfield2010-11
Peter J. Fitzgerald2009-04
Raymond R. Rackley2009-04
Robert P. Cummins2009-04
Registry & provenance

Generic Medical Devices Inc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1397619
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Revascular Therapeutics IncOtherSeries A$25.8M$109.5Mnetwork1 shared operator · same sector · same stage
High Tide Inc.OtherSeries A$17.1M$13.2Msame sector · same stage
Zadspace IncOtherSeries A$18.3M$13.9Msame sector · same stage
Opti-Harvest, Inc.OtherSeries A$19.4M$13.5Msame sector · same stage
Forsyth EMA Holdings, LLCOtherSeries A$13.7M$14.2Msame sector · same stage
Niocorp Developments LtdOtherSeries A$22.3M$14.3Msame sector · same stage
Rheia, LlcOtherSeries A$12.7M$13.4Msame sector · same stage
Flower Ave Inc.OtherSeries A$12.5M$14.0Msame sector · same stage
Frequently asked
How much funding has Generic Medical Devices Inc raised?
Generic Medical Devices Inc has raised approximately $16.9M in disclosed capital across 5 recorded financing rounds, aggregated from public filings.
What is Generic Medical Devices Inc's estimated valuation?
Provath's modeled valuation for Generic Medical Devices Inc is approximately $13.7M (modeled range $1.2M–$74.6M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Generic Medical Devices Inc at?
Generic Medical Devices Inc's latest modeled financing stage is Series A. Its most recent recorded round closed around Tue Sep 13.
What does Generic Medical Devices Inc do and where is it based?
Generic Medical Devices Inc operates in the Other sector, based in GIG HARBOR.
Explore related

See where Generic Medical Devices Inc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Generic Medical Devices Inc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.